MedTrace Logo

Interpretation of Fetal Echocardiography by Artificial Intelligence

NCT05090306 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2021-10-22

No results posted yet for this study

Summary

The study to be performed aims to design and develope an automated Intelligent Decision Support System for fetal echocardiography that can significantly assist the obstetric physician in the improvement of detection of fetal congenital heart disease compared to the common standard of care.

Conditions

  • Congenital Heart Disease

Interventions

DIAGNOSTIC_TEST

Routine ultrasound examination

ULTRASOUND EXAMINATION Women recruited to take part in the study will undergo the routine ultrasound examinations and monitoring, including a fetal echocardiogram between 12-13+6 weeks of gestation (for the first trimester cases) and between 18-24 weeks of gestation (for the second trimester cases). Two-dimensional evaluation of each fetal heart will include a cine loop sweep obtained from the from the four-chamber view plane by moving the transducer cranially towards the upper mediastinum, allowing the visualization of the following planes: four-chamber view, left and right ventricular outflow tracts, three vessels and trachea view. The examination will be stored for further analysis.

Sponsors & Collaborators

  • Romanian Institute of Science and Technology, Cluj-Napoca, Romania

    collaborator UNKNOWN

  • MEDGIN/GINECHO Clinic

    collaborator UNKNOWN

  • University of Medicine and Pharmacy Craiova

    lead OTHER

Principal Investigators

  • Dominic G Iliescu, Assoc. Prof. · University of Medicine and Pharmacy Craiova

  • Anda Ungureanu, PhD(c) · University of Medicine and Pharmacy Craiova

  • Rodica Nagy, PhD(c) · University of Medicine and Pharmacy Craiova

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2022-10-31
Completion
2022-10-31

Countries

  • Romania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05090306 on ClinicalTrials.gov